ADXN
Price
$7.88
Change
-$0.22 (-2.72%)
Updated
Dec 12, 10:30 AM (EDT)
Capitalization
10.73M
Intraday BUY SELL Signals
INKT
Price
$12.42
Change
-$0.13 (-1.04%)
Updated
Dec 12 closing price
Capitalization
58.3M
Intraday BUY SELL Signals
Interact to see
Advertisement

ADXN vs INKT

Header iconADXN vs INKT Comparison
Open Charts ADXN vs INKTBanner chart's image
Addex Therapeutics
Price$7.88
Change-$0.22 (-2.72%)
VolumeN/A
Capitalization10.73M
MiNK Therapeutics
Price$12.42
Change-$0.13 (-1.04%)
Volume$11.4K
Capitalization58.3M
ADXN vs INKT Comparison Chart in %
ADXN
Daily Signal:
Gain/Loss:
INKT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADXN vs. INKT commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a Hold and INKT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (ADXN: $8.10 vs. INKT: $12.55)
Brand notoriety: ADXN and INKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 32% vs. INKT: 56%
Market capitalization -- ADXN: $10.73M vs. INKT: $58.3M
ADXN [@Biotechnology] is valued at $10.73M. INKT’s [@Biotechnology] market capitalization is $58.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 1 FA rating(s) are green whileINKT’s FA Score has 0 green FA rating(s).

  • ADXN’s FA Score: 1 green, 4 red.
  • INKT’s FA Score: 0 green, 5 red.
According to our system of comparison, INKT is a better buy in the long-term than ADXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADXN’s TA Score shows that 4 TA indicator(s) are bullish while INKT’s TA Score has 4 bullish TA indicator(s).

  • ADXN’s TA Score: 4 bullish, 4 bearish.
  • INKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ADXN and INKT are a good buy in the short-term.

Price Growth

ADXN (@Biotechnology) experienced а -3.35% price change this week, while INKT (@Biotechnology) price change was +1.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INKT($58.3M) has a higher market cap than ADXN($10.7M). INKT YTD gains are higher at: 80.083 vs. ADXN (15.714). ADXN has higher annual earnings (EBITDA): -6.17M vs. INKT (-11.23M). INKT has more cash in the bank: 14.3M vs. ADXN (2.19M). ADXN has less debt than INKT: ADXN (36.5K) vs INKT (5.73M). ADXN has higher revenues than INKT: ADXN (31.2K) vs INKT (0).
ADXNINKTADXN / INKT
Capitalization10.7M58.3M18%
EBITDA-6.17M-11.23M55%
Gain YTD15.71480.08320%
P/E RatioN/AN/A-
Revenue31.2K0-
Total Cash2.19M14.3M15%
Total Debt36.5K5.73M1%
FUNDAMENTALS RATINGS
ADXN: Fundamental Ratings
ADXN
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
16
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADXNINKT
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ADXN
Daily Signal:
Gain/Loss:
INKT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FEBO0.890.05
+5.95%
Fenbo Holdings Limited
NMR8.310.19
+2.34%
Nomura Holdings
HTBK12.000.09
+0.76%
Heritage Commerce Corp
ANIK9.49-0.15
-1.56%
Anika Therapeutics
FIZZ34.96-0.57
-1.59%
National Beverage Corp

ADXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
+6.79%
ANVS - ADXN
43%
Loosely correlated
-9.76%
CVM - ADXN
39%
Loosely correlated
-0.77%
XRTX - ADXN
26%
Poorly correlated
+0.15%
ACLX - ADXN
25%
Poorly correlated
+0.99%
ARTV - ADXN
25%
Poorly correlated
+2.28%
More

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-1.49%
RAIN - INKT
43%
Loosely correlated
+2.29%
PHVS - INKT
34%
Loosely correlated
+1.27%
HYPD - INKT
34%
Loosely correlated
-1.31%
TERN - INKT
30%
Poorly correlated
+5.56%
ORMP - INKT
29%
Poorly correlated
+4.66%
More